Paul Weiss Rifkind Wharton And Garris
Recent News About Paul Weiss Rifkind Wharton And Garris
-
Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug
A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.